Cargando…
COVID-19-Vaccine-Pfizer-BioNTech/mycophenolic acid/tacrolimus: Local reaction and lack of efficacy: 2 case reports
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Springer International Publishing
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8569055/ http://dx.doi.org/10.1007/s40278-021-04972-y |
Ejemplares similares
-
COVID-19-Vaccine-Pfizer-BioNTech/ciclosporin/mycophenolate sodium: Vogt-Koyanagi-Harada disease reactivation and lack of efficacy: case report
Publicado: (2021) -
Managing allergic reactions to Pfizer-BioNTech COVID-19 vaccine
Publicado: (2021) -
Adverse reactions with Pfizer/BioNTech's COVID-19 vaccine in Ecuador
Publicado: (2021) -
Severe nonanaphylactic allergic reaction to the Pfizer-BioNTech COVID-19 vaccine
por: Doughty, Hayden, et al.
Publicado: (2021) -
Ad26.COV2-S/COVID-19-Vaccine-Pfizer-BioNTech: Lack of efficacy: case report
Publicado: (2021)